The global Nanoparticle Drug Delivery Systems market size is projected to reach US$ 8103 million by 2027, from US$ 4089 million in 2020, at a CAGR of 10% during 2021-2027.
Nanoparticle drug delivery systems are engineered technologies that use nanoparticles for the targeted delivery and controlled release of therapeutic agents. The modern form of a drug delivery system should minimize side-effects and reduce both dosage and dosage frequency. Recently, nanoparticles have aroused attention due to their potential application for effective drug delivery.
LNPs (liposomal/lipid nanoparticle drug delivery system) became more widely known in late 2020, as some COVID-19 vaccines that use RNA vaccine technology coat the fragile mRNA strands with PEGylated lipid nanoparticles as their delivery vehicle (including both the Moderna and the Pfizer–BioNTech COVID-19 vaccines).
Global Nanoparticle Drug Delivery System Market- Key Players
Johnson & Johnson, Sun Pharmaceutical, CSPC, Kinyond, Teva, Fudan-Zhangjiang, Zydus Cadila, TTY Biopharma, Pacira, Luye Pharma, Leadiant Biosciences, Ipsen, Sayre Therapeutics, Jazz, Alnylam, Bausch Health, Acrotech Biopharma, Takeda, Chiesi Farmaceutici, Gilead Sciences, are some of key suppliers in the market. Gilead Sciences, Pacira, CSPC are top 3 players and own totally 29.86% share in 2020.
The classification of Nanoparticle Drug Delivery Systems includes Liposomes Drugs and Lipid Nanoparticle Drugs. In 2020, Liposomes Drugs accounted for a share of 92.51% in the global Nanoparticle Drug Delivery Systems market. In addition, this product segment is poised to reach US$ 6778 million by 2027 from US$ 4144 million in 2021.
Nanoparticle Drug Delivery Systems is widely used in Hospital, Retail Pharmacy, etc. In Nanoparticle Drug Delivery Systems market, the Retail Pharmacy holds an important share in terms of application, and it is expected to reach a revenue of 4021 million USD by 2027, with a CAGR of 9.21% during 2021 and 2027.
North America is the largest consumption place, with the market share of 35.28% in 2020. Following North America, Asia Pacific is the second largest consumer with the share of 29.31%.
Read More Information: https://www.qyresearch.com/index/detail/3158797/global-nanoparticle-drug-delivery-systems-market
QYResearch provides Market Research Reports for clients all over the world. As of now, QYResearch data as following:
62000 + Clients(cover 100% the world strong 500 companies and most industries’ leading players such as TOP5 players)
7800 + Experts(most of them with more than 15 years’ experience in their industry and professional knowledge both in market and technology)
300 + Data Base(40% government related data base, 30% third part data base, 10% international agencies data base, 30% technology and market data base)
2 Million + Reports(cover almost all industries and most detailed products such as product model level research reports, where you can find all what you need in one shop)
1000 + Custom Research Projects(most clients need custom research service and QYResearch keeps offering good and depth service for them)
30 + Roles Data Interview Checking System(only QYResearch uses such interview system with more than 30 roles in order to confirm the data reliability)
13 + Years focus market research and continues to support the client success.
Rahul Singh - Digital Marketing Director
Contact: +91 7028 920 828 +81-903-800-9273 +86-108-294-5717
Sales Contact US:
USA Registered Office: QY Research, INC.
17890 Castleton, Suite 369,
City of industry, CA - 91748
Emails – firstname.lastname@example.org
Web – www.qyresearch.com